Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from EuroEyes International Eye Clinic Limited ( (HK:1846) ) is now available.
EuroEyes International Eye Clinic Limited has announced its unaudited interim results for the first half of 2025. This announcement, which complies with the listing requirements of the Hong Kong Stock Exchange, provides stakeholders with insights into the company’s financial performance and operational status during this period.
The most recent analyst rating on (HK:1846) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on EuroEyes International Eye Clinic Limited stock, see the HK:1846 Stock Forecast page.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited operates in the healthcare industry, specializing in eye care services. The company focuses on providing advanced eye surgery and treatment options, catering to a market that demands high-quality ophthalmic care.
Average Trading Volume: 159,698
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.01B
See more insights into 1846 stock on TipRanks’ Stock Analysis page.